Congenital Nasolacrimal Duct Obstruction
📧 Sign up to get email alerts when something new happens for Congenital Nasolacrimal Duct Obstruction.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Effect of Standardized Lacrimal Sac Massage Compared With Probing for Congenital Lacrimal Duct Obstruction [NA]
This clinical trial compares standardized lacrimal sac massage with probing for congenital nasolacrimal duct obstruction and is not yet recr…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Recanalization of Congenital Nasolacrimal Duct Obstruction by Endodiathermy Probe and Intubation Versus Intubation Only [Phase 2, Phase 3]
Update on a study comparing endodiathermy probe and intubation versus intubation alone for congenital nasolacrimal duct obstruction in Phase…
-
CLINICAL_TRIALS trial_result · 2019-10-10Clinical Trial Update: Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct [Phase 3]
Phase 3 clinical trial investigating Euphrasia eye drops for congestion of the nasolacrimal duct in preterm infants has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Safety and Efficacy Study of Besivance™ for Treatment of Congenital Nasolacrimal Duct Obstruction in Children [Phase 1]
Phase 1 safety and efficacy study of Besivance (besifloxacin) for treating congenital nasolacrimal duct obstruction in children; the trial i…
-
CLINICAL_TRIALS trial_result · 2015-03-04Clinical Trial Update: Monocanalicular Versus Bicanalicular Intubation in the Treatment of Congenital Nasolacrimal Duct Obstruction [Phase 3]
Phase 3 trial comparing monocanalicular versus bicanalicular intubation for congenital nasolacrimal duct obstruction has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-03-07Clinical Trial Update: The Factors That Affected the Outcome of Treatment of Congenital Nasolacrimal Duct Obstruction
A completed clinical trial analyzing factors that influenced the outcomes of treatments for congenital nasolacrimal duct obstruction.